Foot News and Research

RSS

Biomimetic Therapeutics to discuss Augment Bone Graft data results at AOFAS meeting

BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.

2 Jul 2010

New Stanford Hospital to include one entire floor of hybrid rooms

Whether it's called a hybrid room or an interventional platform, Room 9 at Stanford Hospital & Clinics is that singular space where a patient can stay in one place to be diagnosed and treated, either with surgery or the latest interventional procedure, in an environment as sterile as an operating room, with all-important imaging devices, microscopes and monitors right at hand.

1 Jul 2010

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control.

30 Jun 2010

FDA accepts for review BioMimetic Therapeutics' Augment Bone Graft PMA application

BioMimetic Therapeutics, Inc. today announced the Food & Drug Administration (FDA) has accepted for review its Premarket Approval (PMA) application for Augment™ Bone Graft for use in foot and ankle fusions in the U.S. The FDA has now filed the application and begun the comprehensive review of the clinical module.

29 Jun 2010

Patients should avoid foot facelifts, American Orthopaedic Foot and Ankle Society warns

The American Orthopaedic Foot and Ankle Society is warning patients to avoid "foot facelifts." Cosmetic foot surgery includes narrowing the foot to better fit high heels; shortening the second toe so it's not longer than the big toe and making the little toe shorter and skinnier to accommodate high heels.

28 Jun 2010

VA secretary breaks ground for new 1.5 million-square-foot medical center in New Orleans

Fulfilling President Obama's commitment to rebuild New Orleans, Secretary of Veterans Affairs Eric K. Shinseki joined state and local officials for a ground-breaking ceremony for a new 1.5 million-square-foot medical center for the Department of Veterans Affairs (VA).

28 Jun 2010

National Intrepid Center of Excellence to treat veterans with traumatic brain injury

The U.S. Department of Defense and the Intrepid Fallen Heroes Fund on June 24 officially dedicated the National Intrepid Center of Excellence, a new 72,000-square-foot medical facility in Bethesda, Md., dedicated to researching, diagnosing and treating traumatic brain injury in U.S. military personnel.

28 Jun 2010

$Repetitive impact on feet can increase risk of stress fractures$

Repetitive impact on feet can increase risk of stress fractures

Stress fractures of the foot are becoming more common in runners, especially first-time marathoners, according to the American College of Foot and Ankle Surgeons.

25 Jun 2010

Cellonis' stem cells diabetes treatment helps reconstruct natural insulin production

Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients' conditions. The ongoing clinical study shows the treatment's best case could reconstruct a patient's natural insulin production and even reverse later complications like kidney failure. Treated patients may have the chance to return to the normal activities non-diabetes sufferers take for granted.

24 Jun 2010

SOKO Fitness & Spa Group opens Daoli Fitness and Legend Spa Central Club in Harbin, China

SOKO Fitness & Spa Group, Inc., an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today announced the opening of its two newest facilities, Daoli Fitness and Legend Spa Central Club. Both centers, which, as previously announced, have been engaged in pre-opening activities for several months, are located in the Long Dian Building in downtown Harbin, China, a centrally located building for SOKO's target upper-middle class clients.

23 Jun 2010

Going barefoot in home may contribute to falls among elderly: Study

As summer rolls around, elderly people may want to think twice about taking their shoes off when they get home. Going barefoot in the home, or wearing slippers or socks with no shoes, may contribute to falls among the elderly, according to a new study from the Institute for Aging Research of Hebrew SeniorLife.

23 Jun 2010

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that the U.S. Patent and Trademark Office has issued patent No. 7,714,183 related to the Company's MEDIHONEY Calcium Alginate Dressing.

22 Jun 2010

Access to Healthcare signs contract with World Diabetes Foundation for new healthcare project in India

Coloplast's donation programme Access to Healthcare just signed a contract with the World Diabetes Foundation (WDF) about a new healthcare project in India. The project aims to improve the treatment of diabetic wounds.

22 Jun 2010

Diabetes disease management program helps Medicare patients reduce cost of medical care: Study

Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

FDA grants Pathway 510(k) clearance for JETSTREAM G3 SF peripheral revascularization catheter for PVD

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced that the U.S. Food & Drug Administration (FDA) has granted the company 510(k) clearance to market JETSTREAM G3™ SF (Small Fixed), the newest version of its peripheral revascularization catheter for the treatment of PVD.

21 Jun 2010

Study measures relationship between individual exposure to arsenic and mortality risk

More than 20 percent of deaths in a study of 12,000 Bangladeshis were attributable to arsenic exposure from contaminated drinking water, new research reports.

19 Jun 2010

China Yongxin Pharmaceuticals expands chain of drugstores to 103

China Yongxin Pharmaceuticals Inc., one of the leading health products distribution and retail sales companies in China, today announced the opening of three new chain drugstores in Changchun City. These new openings bring the Company's total number of stores to 24 in Changchun City, and 103 throughout Northeastern China, exceeding the Company's previously projected rate of growth in terms of number of locations.

17 Jun 2010

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that positive results from a prospective study evaluating the AutoloGel™ System to treat advanced, chronic wounds was published in the June 2010 issue of Ostomy Wound Management in a peer reviewed article entitled, "Chronic Wounds Treated With a Physiologically Relevant Concentration of Platelet-rich Plasma (PRP) Gel: A Prospective Case Series."

17 Jun 2010

Senate continues consideration of 'tax extenders,' Democrats push for COBRA subsidy

CongressDaily: The Senate is continuing work on a $140 billion package of tax breaks that includes some unemployment benefits and a temporary fix of the payments to Medicare physicians. "Final passage is not expected until next week on what is likely to be a partisan vote. But there are areas of agreement across the aisle.

11 Jun 2010

AVEO Pharmaceuticals presents tivozanib’s Phase 2 trial data at ASCO meeting

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced data from a subgroup analysis of a Phase 2 randomized discontinuation trial showing that the median progression-free survival (PFS) achieved by patients with advanced clear cell renal cell carcinoma (RCC) who had undergone a prior nephrectomy was 14.8 months.

11 Jun 2010

Foot News and Research

Biomimetic Therapeutics to discuss Augment Bone Graft data results at AOFAS meeting

New Stanford Hospital to include one entire floor of hybrid rooms

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

FDA accepts for review BioMimetic Therapeutics' Augment Bone Graft PMA application

Patients should avoid foot facelifts, American Orthopaedic Foot and Ankle Society warns

VA secretary breaks ground for new 1.5 million-square-foot medical center in New Orleans

National Intrepid Center of Excellence to treat veterans with traumatic brain injury

Repetitive impact on feet can increase risk of stress fractures

Cellonis' stem cells diabetes treatment helps reconstruct natural insulin production

SOKO Fitness & Spa Group opens Daoli Fitness and Legend Spa Central Club in Harbin, China

Going barefoot in home may contribute to falls among elderly: Study

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Access to Healthcare signs contract with World Diabetes Foundation for new healthcare project in India

Diabetes disease management program helps Medicare patients reduce cost of medical care: Study

FDA grants Pathway 510(k) clearance for JETSTREAM G3 SF peripheral revascularization catheter for PVD

Study measures relationship between individual exposure to arsenic and mortality risk

China Yongxin Pharmaceuticals expands chain of drugstores to 103

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Senate continues consideration of 'tax extenders,' Democrats push for COBRA subsidy

AVEO Pharmaceuticals presents tivozanib’s Phase 2 trial data at ASCO meeting

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News